1 Dept of Pediatrics and Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY
2 Hepatitis Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA
In this issue of Pediatrics, the article by Freed and colleagues1 emphasizes important issues in ensuring the implementation of our immunization programs. The effector arm of the program, those who administer the immunizations, must have not only the capability, but also the will. This comes only from understanding the need and rationale of the recommendations.
Freed et al surveyed pediatricians about their awareness and receptivity of the new recommendations for universal infant hepatitis B immunization; the survey was conducted during the 2- to 3-month period between publication of these recommendations from the Centers for Diseases Control and Prevention (CDC)2 and those of the American Academy of Pediatrics (AAP).3
Submitted on January 14, 1993
This article has been cited by other articles:
![]() |
R. J. Oram, R. S. Daum, J. B. Seal, and D. S. Lauderdale Impact of Recommendations to Suspend the Birth Dose of Hepatitis B Virus Vaccine JAMA, April 11, 2001; 285(14): 1874 - 1879. [Abstract] [Full Text] [PDF] |
||||